Search results

Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.

Our projects and partnerships help us anticipate and adapt to policy developments, including changes in health and social care delivery.

NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.

People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.

This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).

The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.

Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.

How providers and commissioners can use quality standards to improve the quality of care

We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.

The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.

A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal

Our forward view highlights the topics we will prioritise in the coming year.

Home What NICE does Our research work HTA Lab...

Past technology appraisal appeals and decisions